Arabesque Asset Management LTD Abb Vie Inc. Transaction History

Arabesque Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $2.09 Million - $2.5 Million	15,083 Added 108.03%	29,045 $4.7 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $1.25 Million - $1.58 Million	9,050 Added 184.24%	13,962 $2.14 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $1.56 Million - $1.93 Million	-11,784 Reduced 70.58%	4,912 $796,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1.79 Million - $2.27 Million	16,696 New	16,696 $2.26 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $1.86 Million - $2.08 Million	-17,723 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $1.81 Million - $2 Million	17,723 New	17,723 $1.92 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Arabesque Asset Management LTD with notifications on news.